Smart Sleep In-home Validation Extension Study
NCT03665844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2018-11-16
Summary
This study is a nonrandomized, unblinded, uncontrolled case series clinical trial validating the SmartSleep product, including SleepMapper app in the home setting. It is intended to provide data related to product use and cognitive testing incorporating a longer baseline period for comparison purposes. It will include adults (21-50 yr. old) who are working full time and report shortened sleep due to lifestyle. For the purposes of this study, shortened sleep is defined as sleeping at least 5 hrs. of sleep per night, and sleeping less than or equal to 7 hrs. at least 3 nights per week. Participants also increase their sleep duration by ≥ 1 hour on the weekends. In addition, participants report a sleep latency ≤ 30 minutes less than or equal to 3 nights per week. Participants are generally healthy individuals who have not been diagnosed with any sleep-related medical conditions. In addition, participants diagnosed with major organ system diseases or requiring oxygen therapy are excluded from participation. Up to 75 individuals will be consented in order to complete a total of 50 participants using a nonrandomized design. The study involves an initial screening visit followed by home use of the SmartSleep device with SleepMapper app. The home use will include an initial week of baseline use followed by 3 weeks of use with boost on. Study staff will contact participants after the first week of use as a reminder. Participants will be asked to complete a battery of cognitive tests upon wake up each morning. Participants will be asked to complete a question twice daily during the home use period. Additional phone calls may occur on an as needed basis if issues arise. The final visit will be an in facility visit in which all study equipment will be returned. The anticipated study duration will be up to 6 weeks (including the 4 weeks of use period).
Conditions
- Healthy
- Sleep Deprivation
- Insufficient Sleep Syndrome
Interventions
- DEVICE
-
SmartSleep Boost On
SmartSleep device can be configured to two different settings. SmartSleep Boost On setting provides soft audio tones during the night. It's a non-invasive portable light weight device designed to stimulate deep slow wave sleep (SWS).
- DEVICE
-
SmartSleep Boost Off
SmartSleep device can be configured to two different settings. SmartSleep Boost Off provides no audio tones.
Sponsors & Collaborators
-
Philips Respironics
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-14
- Primary Completion
- 2018-11-07
- Completion
- 2018-11-07
Countries
- United States
Study Locations
More Related Trials
-
New Versus Existing Auto-titrating CPAP Device to Treat Obstructive Sleep Apnea in Adults
NCT01210261 ·Status: COMPLETED ·Phase: NA
-
Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
NCT00836758 ·Status: COMPLETED ·Phase: NA
-
Validation of Sleep Healthcare System
NCT04252482 ·Status: COMPLETED ·Phase: NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
NCT06381115 ·Status: RECRUITING ·Phase: NA
-
A Study of the Effectiveness and Efficacy of the PowerSleep Device
NCT03162328 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders
NCT01626989 ·Status: COMPLETED ·Phase: NA
-
Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing
NCT02034175 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients
NCT06520592 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Snore Positive Airway Pressure Trial
NCT03201055 ·Status: COMPLETED ·Phase: NA
-
Heart Biomarker Evaluation in Apnea Treatment
NCT01086800 ·Status: COMPLETED ·Phase: PHASE2
-
Derivation and Validation of a Combination of BOSTON Score and DES-OSA Score for Selection of OSA Patients.
NCT03983564 ·Status: COMPLETED
-
Validation of Sleepware G3 Autoscoring Algorithm
NCT01564472 ·Status: WITHDRAWN
-
Validation of the ProSomnus® RPMO2 Device
NCT06267976 ·Status: COMPLETED
-
Positive Pressure Treatment of Obstructive Sleep Apnea
NCT00636181 ·Status: COMPLETED ·Phase: NA
-
OurSleepKit To Support CPAP Adherence
NCT06621511 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device
NCT01241604 ·Status: TERMINATED ·Phase: NA
-
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
NCT02549508 ·Status: COMPLETED ·Phase: NA
-
Workflow Validation of an In-home Auto-titrating Mandibular Positioner
NCT02933112 ·Status: COMPLETED ·Phase: NA
-
CPAP vs ASV for Insomnia
NCT02365064 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device
NCT00720213 ·Status: COMPLETED ·Phase: NA
-
Validation of a Snoring App Against Commercially Available Applications and PSG
NCT07097597 ·Status: NOT_YET_RECRUITING
-
Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study
NCT06769607 ·Status: RECRUITING ·Phase: NA
-
MCI: CPAP Treatment of OSA (Memories2)
NCT03113461 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.
NCT02963597 ·Status: COMPLETED ·Phase: NA
-
Cloud Based Follow up of CPAP Treatment
NCT03446560 ·Status: COMPLETED ·Phase: NA